Article
The effectiveness of retreatment with peginterferon alfa and ribavirin in patients with chronic viral hepatitis C genotype 2 and 3: a prospective cohort study in Brazil.
BMC infectious diseases - 27 Dec 2012
Artico Simara, Amaral Karine Medeiros, Gonçalves Candice Beatriz Treter, Picon Paulo Dornelles
Abstract excerpt
BACKGROUND: More than 50% of patients infected with chronic hepatitis C virus (HCV) do not respond to treatment with conventional interferon (IFN) combined with ribavirin (RBV). The aim of our study was to evaluate the effectiveness of retreatment with peginterferon alfa-2a or 2b (PEG-IFN 2a or 2b) concomitantly with RBV in patients with HCV genotype 2 and 3, which were non-responders or relapsers to initial...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.